课题基金 / 基金详情

SELECTIVE NEURONAL VULNERABILITY IN SPORADIC ALS

SELECTIVE NEURONAL VULNERABILITY IN SPORADIC ALS
散发性肌萎缩侧索硬化症中的选择性神经元脆弱性
批准号:
2271818
负责人:
Stanley H. Appel
金额:
$24.51万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1994
资助国家:
美国
项目状态:
已结题
起止时间:
1994-08-01 至 1998-07-31

项目摘要

项目成果

Stanley H. Appel的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The neurodegenerative diseases including amyotrophic lateral sclerosis (ALS) are devastating idiopathic clinical disorders that result in selective neuronal injury and death. Our general hypothesis is that increased intracellular calcium, produced by active calcium influx across the plasmalemma or release of calcium from intracellular stores, and/or limited calcium buffering capacity, is critically important in neurodegenerative cell injury. Factors dictating selective vulnerability in these diseases may include alterations in any of these processes, likely coupled with selective sensitivity to altered calcium homeostasis. Our own studies of sporadic neurodegenerative disease have documented the presence of antibodies to voltage-gated calcium channels (VGCCs) in sporadic but not familial ALS. ALS IgG produce different electrophysiologically assayed effects on different VGCC types, inhibiting calcium current when added to skeletal muscle L- type VGCCs, while enhancing calcium current, increasing intracellular calcium, and causing cell death when added to neuronal VGCCs in motor neuron cell lines. The motor neuron cell line (VSC 4.1), developed in our laboratory by fusion or murine N18TG2 neuroblastoma line and dissociated embryonic rat ventral spinal cord, expresses biochemical and morphological motor neuron markers as well as neuronal VGCCs when differentiated in the presence of cAMP and aphidocolin. After ALS IgG addition in vitro, there is a marked enhancement of calcium current in differentiated cells (not noted with disease control IgG). Using calcium imaging techniques, ALS IgG also induces a marked, prolonged increase in intracellular calcium, which is followed by VSC 4.1 cell death after twenty-four to seventy-two hours. This cell system will allow us to define ALS IgG-dependent mechanisms permitting prolonged increases in intracellular calcium. We plan to define the relationship in detail between the increased intracellular calcium and the subsequent cell death. Furthermore, since VSC 4.1 cells demonstrate decreased immunohistochemically recognized calbindin D28K and parvalbumin levels during differentiation (concomitant with onset of vulnerability to ALS IgG), a detailed evaluation will be undertaken of the potential role of these calcium binding proteins in selective vulnerability. These studies should aid in understanding the roles played by increased intracellular calcium and altered calcium buffering on selective neuronal vulnerability in sporadic ALS.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Blocking TLR-Activation of Regulatory T cells Slows Disease in ALS
Blocking TLR-Activation of Regulatory T cells Slows Disease in ALS
CLINICAL TRIAL: PHASE I/II TRIAL USING CYCLOPHOSPHAMIDE AND LOW-DOSE IL-2 TO IN
  • 批准号:
    8356778
  • 项目类别:
  • 资助金额:
    $3.13万
  • 财政年份:
    2010
  • 负责人:
    Stanley H. Appel
  • 依托单位:
Using CD4+ T cells as a candidate therapy to slow disease progression in ALS
海外基金